Higher amounts of moderate-to-vigorous physical activity (MVPA) are inversely associated with a lower risk for incident ...
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...
The company hoped to help members take care of their long-term health with tech-powered proactive monitoring and action.
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
People with conditions or habits such as high blood pressure, an irregular heartbeat called atrial fibrillation, or smoking, not only have a higher risk of stroke, they may also have more severe ...